Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan

被引：44

作者：

Cheng, Chien-Yu ^{[1
,2
]}

Lee, Yu-Lin ^{[3
]}

Chen, Cheng-Pin ^{[1
,4
]}

Lin, Yi-Chun ^{[1
]}

Liu, Chun-Eng ^{[3
]}

Liao, Chia-Hung ^{[5
]}

Cheng, Shu-Hsing ^{[1
,6
]}

机构：

[1] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Internal Med, Div Infect Dis, Taoyuan, Taiwan

[2] Natl Yang Ming Univ, Sch Publ Hlth, Taipei, Taiwan

[3] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan

[4] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan

[5] Minist Hlth & Welf, Nantou Hosp, Dept Internal Med, Taoyuan, Taiwan

[6] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan

来源：

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION | 2020年 / 53卷 / 03期

关键词：

COVID-19; SARS CoV-2; Lopinavir/ritonavir (LPV/r); Shedding; THERAPEUTIC-EFFICACY; COMBINATION; RITONAVIR; LOPINAVIR;

D O I：

10.1016/j.jmii.2020.03.032

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1-10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding. Copyright (C) 2020, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.

引用

页码：488 / 492

页数：5

共 17 条

[1]

[Anonymous], 2020, DIAGNOSTIC DETECTION

[2] Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial [J].

Arabi, Yaseen M. ;

Alothman, Adel ;

Balkhy, Hanan H. ;

Al-Dawood, Abdulaziz ;

AlJohani, Sameera ;

Al Harbi, Shmeylan ;

Kojan, Suleiman ;

Al Jeraisy, Majed ;

Deeb, Ahmad M. ;

Assiri, Abdullah M. ;

Al-Hameed, Fahad ;

AlSaedi, Asim ;

Mandourah, Yasser ;

Almekhlafi, Ghaleb A. ;

Sherbeeni, Nisreen Murad ;

Elzein, Fatehi Elnour ;

Memon, Javed ;

Taha, Yusri ;

Almotairi, Abdullah ;

Maghrabi, Khalid A. ;

Qushmaq, Ismael ;

Al Bshabshe, Ali ;

Kharaba, Ayman ;

Shalhoub, Sarah ;

Jose, Jesna ;

Fowler, Robert A. ;

Hayden, Frederick G. ;

Hussein, Mohamed A. .

TRIALS, 2018, 19

[3] Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation [J].

Bernardo, Maria Ester ;

Fibbe, Willem E. .

CELL STEM CELL, 2013, 13 (04) :392-402

[4]

Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]

[5] Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset [J].

Chan, Jasper Fuk-Woo ;

Yao, Yanfeng ;

Yeung, Man-Lung ;

Deng, Wei ;

Bao, Linlin ;

Jia, Lilong ;

Li, Fengdi ;

Xiao, Chong ;

Gao, Hong ;

Yu, Pin ;

Cai, Jian-Piao ;

Chu, Hin ;

Zhou, Jie ;

Chen, Honglin ;

Qin, Chuan ;

Yuen, Kwok-Yung .

JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (12) :1904-1913

[6] Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings [J].

Chu, CM ;

Cheng, VCC ;

Hung, IFN ;

Wong, MML ;

Chan, KH ;

Chan, KS ;

Kao, RYT ;

Poon, LLM ;

Wong, CLP ;

Guan, Y ;

Peiris, JSM ;

Yuen, KY .

THORAX, 2004, 59 (03) :252-256

[7]

Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI [10.1016/j.ijantimicag.2020.105949, 10.1016/j.ijantimicag.2020.106063]

[8]

Groneberg DA, 2005, LANCET INFECT DIS, V5, P147, DOI 10.1016/S1473-3099(05)70022-0

[9]

Holshue ML., 2020, NEW ENGL J MED, V382, P929, DOI DOI 10.1056/NEJMoa2001191

[10] Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths [J].

Lai, Chih-Cheng ;

Liu, Yen Hung ;

Wang, Cheng-Yi ;

Wang, Ya-Hui ;

Hsueh, Shun-Chung ;

Yen, Muh-Yen ;

Ko, Wen-Chien ;

Hsueh, Po-Ren .

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) :404-412

← 1 2 →